Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
10/2003
10/08/2003EP1349847A1 Oxybenzamides derivatives as factor xa inhibitors
10/08/2003EP1349830A1 Tetralone derivatives as antitumor agents
10/08/2003EP1157016B1 A process for the preparation of 2- 2- 4-(diphenylmethyl)-1-piperazinyl]ethoxy acetic acid compounds or salts thereof
10/08/2003EP0994884B1 Diphosphonic acid salts for the treatment of osteoporosis
10/08/2003EP0968171B1 Cationic oxidation bases, their use for oxidation dyeing of keratin fibres, dyeing compositions and dyeing methods
10/08/2003CN1447794A Novel compounds
10/08/2003CN1447791A 10-aryl-11-hbenzo [b] fluorene derivatives and analogs for medicinal use
10/08/2003CN1447789A Compounds to treat alzheimer's disease
10/08/2003CN1123566C Arylsulfonyl hydroxamic acid derivatives
10/07/2003US6630589 Screening assays for compounds that are potentially useful for treating or preventing a proliferative disease. The assays are based on contacting a candidate compound with a cell containing a nucleic acid including a HER2 regulatory element
10/07/2003US6630492 Lymphocyte function antigen-1 antagonists
10/07/2003US6630461 Enyme inhibitors for treating neurodegenerative diseases; inhibition of lipidic peroxidation and nitrogen oxide synthase in warm-blooded animal; for treatment of cardiovascular/brain disorders
10/07/2003CA2270026C Substituted bicyclic derivatives for treating central nervous system disorders
10/07/2003CA2251003C New compounds, derivatives of n-aryl 2-hydroxyalkylamides
10/07/2003CA2094808C Oxysulfonyl urea acat inhibitors
10/02/2003WO2003080586A1 N-sulfonylurea apoptosis promoters
10/02/2003WO2003080568A2 Probucol derivatives
10/02/2003WO2003080554A2 Iodinated triglyceride analogs
10/02/2003WO2003080060A1 Substituted piperazine antithrombotic pai-1 inhibitors
10/02/2003WO2003080053A1 Combination treatments for chemokine-mediated diseases
10/02/2003WO2003080038A1 Preventive or therapeutic agent for kidney disease
10/02/2003WO2003079984A2 Substituted tetracycline compounds
10/02/2003WO2003079983A2 Methods of preparing substituted tetracyclines with transition metal-based chemistries
10/02/2003WO2003079970A2 4-(diarylmethyl)-1-piperazinyl derivatives
10/02/2003WO2002030870A3 Substituted c-cyclohexylmethylamine derivatives
10/02/2003US20030187295 Method for the production of $g(v)-aminoalkylsphonic acids
10/02/2003US20030187164 Solutions of lithium pyrrolidine in tetrahydrofuran (thf)/hydrocarbons
10/02/2003US20030186992 Remedial agent for anxiety neurosis or depression and piperazine derivative
10/02/2003US20030186981 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases
10/02/2003US20030182735 N-benzyl-m-phenylenediamine derivatives and dyes containing said compounds
10/02/2003CA2780743A1 Substituted tetracycline compounds
10/02/2003CA2479254A1 Preventive or therapeutic agent for renal disease
10/01/2003EP1348692A1 Process for the preparation of amine oxides
10/01/2003EP1095008B1 Method for purifying hexamethylenediamine in mixtures of hexamethylenediamine and an unsaturated cyclic imine
10/01/2003CN1446205A (Meth) acrylic acid derivatives and their polymers suitable for use in the manufacture of paper
10/01/2003CN1446200A Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-ichibiting anti-inflammatory and immune-suppressive agents
10/01/2003CN1446197A Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
10/01/2003CN1122662C Arylsulfonylamino hydroxamic acid derivatives
10/01/2003CN1122513C Use of compound in medicine for preparation of inhibiting pathological conditions
09/2003
09/30/2003US6627767 Controlling cellular metabolism
09/30/2003US6627661 Use of 5HT-6 antagonists
09/25/2003WO2003078420A2 Process for making chiral 1,4-disubstituted piperazines
09/25/2003WO2003078376A1 Nk1 antagonists
09/25/2003WO2003077847A2 Substituted amides
09/25/2003WO2003029199A9 Benzene derivatives, process for preparing the same and use thereof
09/25/2003WO2003011844A3 Reagent and method for perfluoroalkylation
09/25/2003WO2003010128A3 Perfluoroalkyl-substituted amines, acids, amino acids and thioether acids
09/25/2003WO2002004433A3 Melanin concentrating hormone receptor ligands
09/25/2003US20030181718 Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents
09/25/2003US20030181688 Coupling of nucleophiles, vinyl compounds or CO with water, alcohols or amines to organic compounds
09/25/2003US20030181464 Phenylsulphonylipiperazinyl derivatives as 5-ht receptor ligands
09/25/2003US20030181452 Inotropic agents such as (S)-N-tert-butyloxycarbonyl-N-methyl-tyrosyl)-4-(4-nitrophenyl)-piperazine, used for preventing and/or prophylaxis of diseases associated with adenosine 5'-triphosphate
09/25/2003US20030181443 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof
09/25/2003US20030181442 Carbamides such as N-(3-tert-butylphenyl)-N'-(4-(3-(N-methyl-carbamoyl)phenoxy)phenyl urea, used as enzyme inhibitors and as anticarcinogenic agents
09/25/2003US20030181390 Sustained release of aminobutyric acid using prodrugs such as L-1-naphthylalanine-gabapentin, administered for prophylaxis of nervous system disorders, as anxiolytics, antidepressants or antiinflammatory agents; drug delivery
09/25/2003CA2478211A1 Nk1 antagonists
09/25/2003CA2477906A1 Process for making chiral 1,4-disubstituted piperazines
09/24/2003EP1345952A2 Isolation of nucleic acids
09/24/2003EP1345899A1 Compounds
09/24/2003EP1043308B1 Phenylaminoalkylcarboxylic acid derivatives and medicinal compositions containing the same
09/24/2003EP0984959B1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
09/24/2003CN1444579A 2,2-disubstituted 1,3,-dioxolanes as antitussive agents
09/24/2003CN1444578A 1,3-dioxolanes with antitussive activity
09/24/2003CN1444573A Carboxamide compounds and their use as antagonists of human 11CBY receptor
09/24/2003CN1122019C Tetralines bearing phenyl substituant on aromatic ring and their use in treatment of epilepsy, stroke and brain of spinal trauma
09/24/2003CN1122018C 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
09/23/2003USRE38257 Piperdine derivatives and hypotensives containing the same
09/23/2003US6624304 Halogenation, hydrofluorination, cyclization, salt formation, cyclization; reaction with piperazine; separation
09/23/2003US6624194 Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
09/23/2003US6624169 Urokinase inhibitors
09/23/2003US6623731 Modified amino acid compounds useful in the drug delivery of bioactive agents such as recombinant human growth hormone (rhGH); dosage units; synthesis
09/18/2003WO2003076438A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076430A1 Amino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076422A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076421A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076406A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
09/18/2003WO2003076400A1 New inhibitors of histone deacetylase
09/18/2003WO2003076397A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003WO2003076395A1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076386A2 Catalysts and method for the production of amines
09/18/2003WO2003076374A1 PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE
09/18/2003WO2003075929A1 Inhibitors of histone deacetylase
09/18/2003WO2003075907A2 Small molecule entry inhibitors
09/18/2003WO2003075857A2 Amino-methyl substituted tetracycline compounds
09/18/2003WO2003075853A2 Cyclic derivatives as modulators of chemokine receptor activity
09/18/2003WO2003075836A2 Cathepsin cysteine protease inhibitors
09/18/2003WO2003053915A3 Compounds for the treatment of inflammatory disorders
09/18/2003WO2003011851A3 Aromatic hydroxamic acid derivatives useful as hdac inhibitors
09/18/2003WO2002076925A3 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
09/18/2003US20030176497 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
09/18/2003US20030176495 HIV Integrase inhibitors
09/18/2003US20030176465 Cyclic amino acid derivatives
09/18/2003US20030176447 For therapy of cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease
09/18/2003US20030176446 2,2-disubstituted 1,3-dioxolanes as antitussive agents
09/18/2003US20030176441 Inhibitsthe binding of eotaxin to the CCR-3 receptor and thereby provide a means of combating eosinophil induced diseases, such as asthma
09/18/2003US20030176440 For protecting skeletal muscles against damage resulting from trauma, protecting skeletal muscles subsequent to muscle or systemic diseases, therapy of shock conditions, preserving donor tissue and organs used in transplants
09/18/2003US20030176439 For therapy and prophylaxis of thromboembolic diseases and restenoses; reversible inhibitors of the blood clotting enzyme factor VIIa
09/18/2003US20030175848 For use as alternative substrates for NAD(P)H-dependent disulphide-reductase enzymes such as trypanothion reductase and thioredoxine reductase
09/18/2003US20030172471 1,3-diamino-4-(aminomethyl) - benzene derivatives and colorants containing the said compounds
09/18/2003CA2479065A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
1 ... 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 ... 341